Subscribe

Receive updates about our latest products in your inbox

Register For Our Next Webinar

Beyond the Buzzword: Practical Detoxification Strategies for Clinicians

About Us

For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional

Search the Blog

  • There are no suggestions because the search field is empty.

Berberine Determined to be Beneficial Against Candida Albicans

blossoming_barberryBerberine is recognized as having antibacterial activity, and has demonstrated such activity against “staphylococcal, streptococcal, and enterococcal species, including multi drug resistant strains of Mycobacterium tuberculosis and MRSA” (methicillin-resistant Staphylococcus aureus). In in vitro studies berberine was demonstrated to have “activity against clinical isolates of MRSA, with minimal inhibitory concentration (MICs) ranging from 32 to 128 μg/mL.” Additionally, berberine demonstrated synergism with antifungal medications (amphotericin, fluconazole, and miconazole) thus may be beneficial for opportunistic infections resistant to antibiotics. Previous studies also observed that berberine did not instill bacterial resistance, “since [the] MIC of berberine within same bacterial cultures (E. coli, S. aureus, Bacillus subtilis, Proteus vulgaris, S. typhimurium and P. aeruginosa) did not increase over 200 generations.” Thus, berberine may be viewed as a potential alternative or adjunctive therapy for the treatment and/or prevention of candidiasis.

Ref: Zorić N, Kosalec I, Tomić S, Bobnjarić I, Jug M, Vlainić T, Vlainić J. Membrane of Candida albicans as a target of berberine. BMC Complementary and Alternative Medicine. (2017) 17:268. DOI 10.1186/s12906-017-1773-5.

 

Share This: 
 

Submit your comment

Related Post